Victory Capital Management
GSK icon

Victory Capital Management’s GSK GSK Stock Holding History

Victory Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-27,739
Closed -$1.01M – 2570
2023
Q3 		$1.01M Hold
27,739
– – ﹤0.01% 1654
2023
Q2 		$989K Hold
27,739
– – ﹤0.01% 1687
2023
Q1 		$987K Buy
+27,739
New +$970K ﹤0.01% 1699

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management's GSK Position: Q4 2023 in Review

Victory Capital Management sold out of GSK (GSK) in Q4 2023, closing a stake of 27,739 shares — an estimated $1.01M sold.

Victory Capital Management first reported a position in GSK in Q1 2023 and held it in 3 quarters. The position peaked at $1.01M in Q3 2023. 895 funds tracked by Wall St. Rank hold GSK as of Q4 2023.

  • Victory Capital Management reported no remaining GSK position as of Q4 2023 after selling out during the quarter.
  • Victory Capital Management sold 27,739 GSK shares in Q4 2023, an estimated $1.01M.
  • Victory Capital Management first reported a position in GSK in Q1 2023 and held it in 3 quarters.
  • Victory Capital Management's GSK position peaked at $1.01M in Q3 2023.
  • 895 funds tracked by Wall St. Rank held GSK as of Q4 2023.

Based on Victory Capital Management's 13F filing for Q4 2023, filed 5 Feb 2024.